Clinical experience with metolazone in fifty-two African patients: synergy with frusemide

The use of metolazone (Zaroxolyn), a new diuretic, in fifty-two African patients is described. The drug was found to be safe and moderately effective when used alone, but combined with frusemide it proved to be of great value in patients whose fluid retention was refractory to other diuretics.

[1]  A. Guz,et al.  Observations of renal function in patients undergoing therapeutic diuresis with frusemide. , 1970, Clinical science.

[2]  Dreiling Da.  The lymphatics, pancreatic ascites, and pancreatic inflammatory disease. A new therapy for pancreatitis. , 1970 .

[3]  A. Borrelli,et al.  Antagonism to the Diuretic Action of SR 720-22 , 1969, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[4]  H. E. Williamson,et al.  ADDITION OF THE SALURETIC ACTION OF FUROSEMIDE TO THE SALURETIC ACTION OF CERTAIN OTHER AGENTS. , 1965, The Journal of pharmacology and experimental therapeutics.

[5]  G. Teasdale,et al.  THE DIURETIC RESPONSE TO FRUSEMIDE. , 1964, Lancet.

[6]  C. Ross,et al.  Blockade of the diuretic action of benzothiadiazines. , 1963, The Journal of pharmacology and experimental therapeutics.

[7]  A. Borelli,et al.  Pharmacology of SR 720-22. , 1969, Archives internationales de pharmacodynamie et de therapie.